HK1243351A1 - 一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物 - Google Patents

一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物

Info

Publication number
HK1243351A1
HK1243351A1 HK18102971.9A HK18102971A HK1243351A1 HK 1243351 A1 HK1243351 A1 HK 1243351A1 HK 18102971 A HK18102971 A HK 18102971A HK 1243351 A1 HK1243351 A1 HK 1243351A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutically acceptable
pharmaceutical composition
acceptable salt
pyridopyrimidine derivative
pyridopyrimidine
Prior art date
Application number
HK18102971.9A
Other languages
English (en)
Inventor
盧韻
張新華
丁歡
張代美
Original Assignee
江蘇恒瑞醫藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江蘇恒瑞醫藥股份有限公司 filed Critical 江蘇恒瑞醫藥股份有限公司
Publication of HK1243351A1 publication Critical patent/HK1243351A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK18102971.9A 2016-02-04 2018-03-01 一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物 HK1243351A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610080476 2016-02-04
PCT/CN2017/072213 WO2017133542A1 (zh) 2016-02-04 2017-01-23 一种含有吡啶并嘧啶类衍生物或其可药用盐的药物组合物

Publications (1)

Publication Number Publication Date
HK1243351A1 true HK1243351A1 (zh) 2018-07-13

Family

ID=59500122

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18102971.9A HK1243351A1 (zh) 2016-02-04 2018-03-01 一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物

Country Status (4)

Country Link
CN (1) CN107405350A (zh)
HK (1) HK1243351A1 (zh)
TW (1) TWI737673B (zh)
WO (1) WO2017133542A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020253808A1 (zh) * 2019-06-20 2020-12-24 江苏恒瑞医药股份有限公司 一种药物组合物以及其制备方法
TW202245782A (zh) * 2021-03-03 2022-12-01 大陸商蘇州盛迪亞生物醫藥有限公司 一種包含吡啶并嘧啶類衍生物的醫藥組成物及其製備方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3501696A1 (de) * 1985-01-19 1986-07-24 Bayer Ag, 5090 Leverkusen Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
WO2014183520A1 (zh) * 2013-05-17 2014-11-20 上海恒瑞医药有限公司 吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用
CN106795159B (zh) * 2015-04-22 2018-12-28 江苏恒瑞医药股份有限公司 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法

Also Published As

Publication number Publication date
CN107405350A (zh) 2017-11-28
WO2017133542A1 (zh) 2017-08-10
TWI737673B (zh) 2021-09-01
TW201728329A (zh) 2017-08-16

Similar Documents

Publication Publication Date Title
IL257481B (en) Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof
HK1259145A1 (zh) 3-脫氧衍生物及其藥物組合物
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
HK1244704A1 (zh) 一種含有jak激酶抑制劑或其可藥用鹽的藥物組合物
EP3480198A4 (en) NEW COMPOUND OR ITS PHARMACEUTICALLY ACCEPTED SALT
IL255823A (en) Urea derivative or pharmacologically acceptable salt thereof
ZA201601656B (en) Inhalable pharmaceutical composition
IL256339B (en) A derivative of pyrazole or its pharmacy salt
HK1254573A1 (zh) 包含苯基氨基嘧啶衍生物的藥物組合物
HK1255313A1 (zh) 含有培美曲塞或其藥學上可接受的鹽的穩定藥物組合物
IL263040A (en) Pharmaceutical composition comprising eteplirsen
HK1245646A1 (zh) 口服給藥用醫藥組合物
HK1243351A1 (zh) 一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物
EP3361250A4 (en) PHARMACEUTICAL COMPOSITION FOR INDUCTION OF EXERCISE EFFECTS
PL3313370T3 (pl) Okulistyczna kompozycja farmaceutyczna
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
HK1243358B (zh) 一種含有喹啉衍生物或其鹽的藥物組合物
HUE057830T2 (hu) Famitinib tartalmú gyógyszerkészítmény
EP3351245A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
EP3222271A4 (en) Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof
HUP1400520A2 (hu) Gyógyászati készítmény elõállítására alkalmazható laquinimod sók